Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
After finishing at $13.85 in the prior trading day, PACS Group Inc (NYSE: PACS) closed at $13.3, down -3.97%. In other words, the price has decreased by -$3.97 from its previous closing price. On the day, 0.94 million shares were traded. PACS stock price reached its highest trading level at $14.07 during the session, while it also had its lowest trading level at $12.98.
On October 09, 2024, UBS started tracking the stock assigning a Buy rating and target price of $50.UBS initiated its Buy rating on October 09, 2024, with a $50 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PACS now has a Market Capitalization of 2149208576 and an Enterprise Value of 4673633280. Its current Enterprise Value per Revenue stands at 1.313 whereas that against EBITDA is 18.771.
Stock Price History:
The Beta on a monthly basis for PACS is 1.08, which has changed by -0.6590618 over the last 52 weeks, in comparison to a change of 0.15927899 over the same period for the S&P500. Over the past 52 weeks, PACS has reached a high of $43.92, while it has fallen to a 52-week low of $7.50. The 50-Day Moving Average of the stock is 13.65%, while the 200-Day Moving Average is calculated to be 12.25%.
Shares Statistics:
The stock has traded on average 888.13K shares per day over the past 3-months and 1012000 shares per day over the last 10 days, according to various share statistics. A total of 152.40M shares are outstanding, with a floating share count of 39.10M. Insiders hold about 74.80% of the company’s shares, while institutions hold 28.93% stake in the company. Shares short for PACS as of 1757894400 were 3187517 with a Short Ratio of 3.59, compared to 1755216000 on 2496590.
Earnings Estimates
. The current assessment of PACS Group Inc (PACS) involves the perspectives of 2 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $0.38, with high estimates of $0.4 and low estimates of $0.37.
Analysts are recommending an EPS of between $1.61 and $1.44 for the fiscal current year, implying an average EPS of $1.52. EPS for the following year is $1.86, with 2.0 analysts recommending between $1.9 and $1.82.
Revenue Estimates
For the next quarter, 2 analysts are estimating revenue of $1.05B. There is a high estimate of $1.07B for the next quarter, whereas the lowest estimate is $1.02B.
Based on 2 analysts’ estimates, the company’s revenue will be $4.53B in the next fiscal year. The high estimate is $4.61B and the low estimate is $4.45B.
